Public Health - Medetomidine and Xylazine Consumer Protection Act
What this bill does
Prohibiting a retailer from distributing, selling, or exposing for sale a medetomidine product or xylazine product unless the purchaser provides proof the intended use is for institutional, veterinary, or scientific purposes; prohibiting a retailer from distributing, selling, or exposing for sale a medetomidine or xylazine product to an individual under the age of 21 years; requiring a retailer that prepares, distributes, sells, or exposes for sale a medetomidine or xylazine product to maintain certain records; etc.
Analysis reads the bill text, the fiscal note, and the witness list. It is generated by Claude and reviewed by nobody, so check the source documents before you rely on it.
Testimony (6)
MGA witness list| Position | Witness | Organization | Testimony |
|---|---|---|---|
| FAV | Rosier, Collanlobbyist | Pyramid Healthcare, Inc. | Position only |
| FAV | Mauer, William | Individual | Position only |
| FAV | Senator Folden, Senator Foldenlegislator | Individual | Oral |
| FAV | Tibbals, Trudy | Individual | Position only |
| FAV | Vetter, Drew | Individual | Written (PDF) |
| UNF | Bauer, Danielle | Maryland Veterinary Medical Association | Written (PDF) |